THE ORIGINAL CONVENIENT PREFILLED, NO-MIX SYRINGE FOR GnRH TREATMENT OF ADVANCED PROSTATE CANCER IN ADULTS

CAMCEVI® is still the first and only sub-Q leuprolide therapy in a prefilled, no-mix, ready-to-inject formulation that simplifies GnRH agonist preparation—offering consistent testosterone suppression, after the initial injection, to castrate levels from Week 4 to Week 48.1

Don’t sweat syringe prep1

Don’t SweatThe Schedule

Keep patients on schedule. Simply click or tap the dosage dial and rotate to schedule your patient’s next treatment date.*

*Recommended Dosage: 42 mg subcutaneously every 6 months.

Hand Rotator
Rotate wheel
Current Dose
Next Dose
02/25/24
PROVEN LEUPROLIDE EFFICACY

PROVEN
LEUPROLIDE EFFICACY

CAMCEVI offers proven leuprolide efficacy in a convenient prefilled, no-mix syringe.1


SIMPLIFIED PREPARATION

SIMPLIFIED
PREPARATION

CAMCEVI comes prefilled with no mixing required—simplifying syringe prep for you.1


SIMPLIFIED PREPARATION

DON’T SWEAT
THE J CODE

Permanent J Code J1952 is unique to CAMCEVI and unaffected by market price changes.

Don’t sweat
the coverage2,3

*As of 02/01/24.
Coverage is not indicative of
utilization management criteria.

96%

patients covered by

Medicare*

91%

patients covered by

Commercial*

*As of 02/01/24.
Coverage is not indicative of
utilization management criteria.

Real stories from real people

Watch healthcare professionals talk about their experiences with CAMCEVI.*

NURSE

video-preview

Sarah L.

“Our patients have stayed at castration level so we have not had to switch a patient off of CAMCEVI.”

View more CAMCEVI testimonials.

*As with all medications, individual patient experiences may vary.

PROVEN LEUPROLIDE EFFICACY

LIVES AND GROWING*

Patients who have undergone treatment on CAMCEVI4

*As of 12/31/2023.

Don’t sweat YOUR ORDER

Order CAMCEVI through our distribution and GPO partners.

Learn more

HAVE A QUESTION?

Let us simplify it for you.

CONNECT WITH A REPRESENTATIVE

    GET UPDATES

    Stay informed about
    CAMCEVI with regular updates,
    education, and more.

    *Required fields

    References:

    1. CAMCEVI. Prescribing information. Accord BioPharma; May 2021. 2. Data on file. Accord BioPharma; 2023. 3. Data on file. Accord BioPharma; 2023. 4. Data on file. Accord BioPharma; 2023.